Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Abu El Asrar, Ahmed M ^a,b   Nawaz, Mohd Imtiaz ^a   Kangave, Dustan ^a   Mairaj Siddiquei, Mohammed ^a   Geboes, Karel ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; VITREOUS BODY;

EID: 84879327717     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/539658     Document Type: Article

References (48)

1. Dome B., Dobos J., Tovari J., Paku S., Kovacs G., Ostoros G., Timar J., Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry A 2008 73 3 186 193 2-s2.0-40049087424 10.1002/cyto.a.20480 (Pubitemid 351323747)
2. Asahara T., Murohara T., Sullivan A., Silver M., Van Der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J. M., Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 5302 964 967 2-s2.0-0031019745 10.1126/science.275.5302.964 (Pubitemid 27087709)
3. Abu El-Asrar A. M., Struyf S., Verbeke H., Van Damme J., Geboes K., Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes. Acta Ophthalmologica 2011 89 3 222 228 2-s2.0-79954986853 10.1111/j.1755-3768.2009.01700.x
4. Abu El-Asrar A. M., Struyf S., Opdenakker G., van Damme J., Geboes K., Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes. Molecular Vision 2010 16 1098 1107 2-s2.0-77955647882
5. Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Gravereaux E., Pieczek A., Iwaguro H., Hayashi S. I., Isner J. M., Asahara T., Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circulation Research 2000 86 12 1198 1202 2-s2.0-0034705367 (Pubitemid 30436658)
6. Li B., Sharpe E. E., Maupin A. B., Teleron A. A., Pyle A. L., Carmeliet P., Young P. P., VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB Journal 2006 20 9 E664 E676 2-s2.0-33845707705 10.1096/fj.05-5137fje (Pubitemid 44961985)
7. Shibuya M., Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. Journal of Biochemistry and Molecular Biology 2006 39 5 469 478 2-s2.0-33750842076 (Pubitemid 44714526)
8. Ebos J. M. L., Bocci G., Man S., Thorpe P. E., Hicklin D. J., Zhou D., Jia X., Kerbel R. S., A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma. Molecular Cancer Research 2004 2 6 315 326 2-s2.0-3543131382 (Pubitemid 39025294)
9. Ebos J. M. L., Lee C. R., Bogdanovic E., Alami J., Van Slyke P., Francia G., Xu P., Mutsaers A. J., Dumont D. J., Kerbel R. S., Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Cancer Research 2008 68 2 521 529 2-s2.0-39049165334 10.1158/0008-5472.CAN-07-3217 (Pubitemid 351380080)
10. Fazel S. S., Chen L., Angoulvant D., Li S. H., Weisel R. D., Keating A., Li R. K., Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury. FASEB Journal 2008 22 3 930 940 2-s2.0-40449105049 10.1096/fj.07-8636com (Pubitemid 351348144)
11. Huang P. H., Chen Y. H., Wang C. H., Chen J. S., Tsai H. Y., Lin F. Y., Lo W. Y., Wu T. C., Sata M., Chen J. W., Lin S. J., Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor Cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 8 1179 1184 2-s2.0-68149099660 10.1161/ATVBAHA.109. 189175
12. Heissig B., Werb Z., Rafii S., Hattori K., Role of c-kit/Kit ligand signaling in regulating vasculogenesis. Thrombosis and Haemostasis 2003 90 4 570 576 2-s2.0-0142092593 (Pubitemid 37287623)
13. Li T. S., Hamano K., Nishida M., Hayashi M., Ito H., Mikamo A., Matsuzaki M., CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. American Journal of Physiology 2003 285 3 H931 H937 2-s2.0-0041358457 (Pubitemid 37048145)
14. Miyamoto Y., Suyama T., Yashita T., Akimaru H., Kurata H., Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. Journal of Molecular and Cellular Cardiology 2007 43 5 627 635 2-s2.0-35448954459 10.1016/j.yjmcc.2007.08.001 (Pubitemid 47616261)
15. Dentelli P., Rosso A., Balsamo A., Benedetto S. C., Zeoli A., Pegoraro M., Camussi G., Pegoraro L., Brizzi M. F., C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood 2007 109 10 4264 4271 2-s2.0-34248386939 10.1182/blood-2006- 06-029603 (Pubitemid 46743392)
16. Matsui J., Wakabayashi T., Asada M., Yoshimatsu K., Okada M., Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. Journal of Biological Chemistry 2004 279 18 18600 18607 2-s2.0-2442631556 10.1074/jbc.M311643200 (Pubitemid 38623281)
17. Sun L., Hui A. M., Su Q., Vortmeyer A., Kotliarov Y., Pastorino S., Passaniti A., Menon J., Walling J., Bailey R., Rosenblum M., Mikkelsen T., Fine H. A., Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006 9 4 287 300 2-s2.0-33645772227 10.1016/j.ccr.2006. 03.003
18. Kelly D. J., Zhang Y., Gow R. M., Itescu S., Gilbert R. E., Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes. Diabetes and Vascular Disease Research 2005 2 2 76 80 2-s2.0-20444501445 (Pubitemid 40827000)
19. Turner A. M., Bennett L. G., Lin N. L., Wypych J., Bartley T. D., Hunt R. W., Atkins H. L., Langley K. E., Parker V., Martin F., Broudy V. C., Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines. Blood 1995 85 8 2052 2058 2-s2.0-0028912708
20. Kaminski A., Ma N., Donndorf P., Lindenblatt N., Feldmeier G., Ong L. L., Furlani D., Skrabal C. A., Liebold A., Vollmar B., Steinhoff G., Endothelial NOS is required for SDF-1 α /CXCR4-mediated peripheral endothelial adhesion of c-kit+ bone marrow stem cells. Laboratory Investigation 2008 88 1 58 69 2-s2.0-37549034316 10.1038/labinvest.3700693
21. Zheng H., Fu G., Dai T., Huang H., Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1 α /CXCR4 via PI3K/Akt/eNOS signal transduction pathway. Journal of Cardiovascular Pharmacology 2007 50 3 274 280 2-s2.0-34548710861 10.1097/FJC.0b013e318093ec8f (Pubitemid 47428975)
22. Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., Technau-Ihling K., Zeiher A. M., Dimmeler S., Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nature Medicine 2003 9 11 1370 1376 2-s2.0-0345276632 10.1038/nm948 (Pubitemid 37466185)
23. Hiasa K.-I., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S., Sata M., Ichiki T., Takeshita A., Egashira K., Gene transfer of stromal cell-derived factor-1 α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004 109 20 2454 2461 2-s2.0-2542464782 10.1161/01.CIR.0000128213. 96779.61 (Pubitemid 38679567)
24. Herrler T., Leicht S. F., Huber S., Hermann P. C., Schwarz T. M., Kopp R., Heeschen C., Prostaglandin e positively modulates endothelial progenitor cell homeostasis: an advanced treatment modality for autologous cell therapy. Journal of Vascular Research 2009 46 4 333 346 2-s2.0-58149355452 10.1159/000189794
25. 2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells. Vascular Pharmacology 2006 44 6 411 416 2-s2.0-33646760266 10.1016/j.vph.2006.02.009 (Pubitemid 43766677)
26. Aiello L. P., Avery R. L., Arrigg P. G., Keyt B. A., Jampel H. D., Shah S. T., Pasquale L. R., Thieme H., Iwamoto M. A., Park J. E., Nguyen H. V., Aiello L. M., Ferrara N., King G. L., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine 1994 331 22 1480 1487 2-s2.0-0027942607 10.1056/NEJM199412013312203 (Pubitemid 24356306)
27. Jantus-Lewintre E., Sanmartīn E., Sirera R., Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC. Lung Cancer 2011 74 2 326 331 10.1016/j.lungcan. 2011.02.016
28. Swendeman S., Mendelson K., Weskamp G., Horiuchi K., Deutsch U., Scherle P., Hooper A., Rafii S., Blobel C. P., VEGF-a stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between vegfr2 and ERK signaling. Circulation Research 2008 103 9 916 918 2-s2.0-55449114832 10.1161/CIRCRESAHA.108.184416
29. Stachon A., Aweimer A., Stachon T., Tannapfel A., Thoms S., Ubrig B., Köller M., Krieg M., Truss M. C., Secretion of soluble VEGF receptor 2 by microvascular endothelial cells derived by human benign prostatic hyperplasia. Growth Factors 2009 27 2 71 78 2-s2.0-66949162989 10.1080/08977190802709619
30. Abu El-Asrar A. M., Missotten L., Geboes K., Expression of cyclo-oxygenase-2 and downstream enzymes in diabetic fibrovascular epiretinal membranes. British Journal of Ophthalmology 2008 92 11 1534 1539 2-s2.0-55449103992 10.1136/bjo.2008.142182
31. Litz J., Krystal G. W., Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1 α activity and vascular endothelial growth factor expression in small cell lung cancer cells. Molecular Cancer Therapeutics 2006 5 6 1415 1422 2-s2.0-33746072622 10.1158/1535-7163.MCT-05-0503 (Pubitemid 44070477)
32. Pedersen M., Löfstedt T., Sun J., Holmquist-Mengelbier L., Påhlman S., Rönnstrand L., Stem cell factor induces HIF-1 α at normoxia in hematopoietic cells. Biochemical and Biophysical Research Communications 2008 377 1 98 103 2-s2.0-54449090771 10.1016/j.bbrc.2008.09.102
33. Han Z.-B., Ren H., Zhao H., Chi Y., Chen K., Zhou B., Liu Y. J., Zhang L., Xu B., Liu B., Yang R., Han Z. C., Hypoxia-inducible factor (HIF)-1 α directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 2008 29 10 1853 1861 2-s2.0-51849108509 10.1093/carcin/bgn066
34. Abd El-Asrar A. M. A., Missotten L., Geboes K., Expression of hypoxia-inducible factor-1 α and the protein products of its target genes in diabetic fibrovascular epiretinal membranes. British Journal of Ophthalmology 2007 91 6 822 826 2-s2.0-34249814615 10.1136/bjo.2006.109876 (Pubitemid 46846660)
35. Demetri G. D., Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors. Seminars in Oncology 2011 38 supplement 1 S10 S19 2-s2.0-79952763618 10.1053/j.seminoncol.2011.01.018
36. Takeshima H., Kuratsu J. I., A review of soluble c-kit (s-kit) as a novel tumor marker and possible molecular target for the treatment of CNS germinoma. Surgical Neurology 2003 60 4 321 324 2-s2.0-0141737843 10.1016/S0090-3019(03) 00430-0 (Pubitemid 37162631)
37. DePrimo S. E., Huang X., Blackstein M. E., Garrett C. R., Harmon C. S., Schöffski P., Shah M. H., Verweij J., Baum C. M., Demetri G. D., Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure. Clinical Cancer Research 2009 15 18 5869 5877 2-s2.0-70349452663
38. Kawakita M., Yonemura Y., Miyake H., Ohkubo T., Asou N., Hayakawa K., Nakamura M., Kitoh T., Osawa H., Takatsuki K., Suda T., Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders. British Journal of Haematology 1995 91 1 23 29 2-s2.0-0029046519
39. Akin C., Schwartz L. B., Kitoh T., Obayashi H., Worobec A. S., Scott L. M., Metcalfe D. D., Soluble stem cell factor receptor (CD 117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology. Blood 2000 96 4 1267 1273 2-s2.0-0034663031 (Pubitemid 30658453)
40. Nakamura Y., Tajima F., Ishiga K., Yamazaki H., Oshimura M., Shiota G., Murawaki Y., Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice. Experimental Hematology 2004 32 4 390 396 2-s2.0-1642634596 10.1016/j.exphem.2004.01.004 (Pubitemid 38410916)
41. Ishiga K., Serum-soluble c-kit levels during mobilization of peripheral blood stem cells correlate with stem cell yield. International Journal of Hematology 2000 72 2 186 193 2-s2.0-0034242184
42. Joensuu H., Puputti M., Sihto H., Tynninen O., Nupponen N. N., Amplification of genes encoding KIT, PDGFR α and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. Journal of Pathology 2005 207 2 224 231 2-s2.0-26044467362 10.1002/path.1823 (Pubitemid 41404153)
43. Turner A. M., Bennett L. G., Lin N. L., Wypych J., Bartley T. D., Hunt R. W., Atkins H. L., Langley K. E., Parker V., Martin F., Broudy V. C., Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines. Blood 1995 85 8 2052 2058 2-s2.0-0028912708
44. Ying L., Hofseth L. J., An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Research 2007 67 4 1407 1410 2-s2.0-33847711009 10.1158/0008-5472.CAN-06-2149 (Pubitemid 46383362)
45. Minshall R. D., Sessa W. C., Stan R. V., Anderson R. G. W., Malik A. B., Caveolin regulation of endothelial function. American Journal of Physiology 2003 285 6 L1179 L1183 2-s2.0-0344496103 (Pubitemid 37448786)
46. Douros S., Phillips B. A., Nadel A., Obstbaum S. A., Human vitreal prostaglandin levels and proliferative diabetic retinopathy. Documenta Ophthalmologica 2001 103 1 27 34 2-s2.0-0034804930 10.1023/A:1017557600233 (Pubitemid 32926913)
47. Descamps F. J., Martens E., Kangave D., Struyf S., Geboes K., Van Damme J., Opdenakker G., Abu El-Asrar A. M., The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage. Experimental Eye Research 2006 83 2 401 407 2-s2.0-33744918292 10.1016/j.exer.2006.01.017 (Pubitemid 43850955)
48. Abu El-Asrar A. M., Struyf S., Kangave D., Geboes K., Van Damme J., Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. European Cytokine Network 2006 17 3 155 165 2-s2.0-39049193307